Study S001484

A Placebo- and Positive-Controlled Study of the Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00672399
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: COMPLETED
Enrollment: 70
Start: 2008-04
Primary completion: 2008-07
Lead sponsor: AstraZeneca
Conditions: Healthy Subjects
Interventions: DRUG:exenatide; DRUG:Moxifloxacin; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Comparison of exenatide's effect on QT interval when compared to placebo [single doses - measurements at 1, 2, 3, 4, 5.5 and 10 hours after dosing]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.